Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)
Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
Study OPL-0301-201 is intended to generate efficacy and safety data of OPL-0301 in
participants with post-myocardial infarction (MI) left ventricular dysfunction (LVD)